Study design (if review, criteria of inclusion for studies)
randomised single blind crossover study
Participants
39 children with cystic fibrosis and pancreatic insufficiency
Interventions
Pancrease followed by Creon or vice versa, four weeks' treatment with each preparation
Outcome measures
coefficient of fat absorption, nitrogen excretion, weight change, and symptom scores
Main results
Results showed no significant differences between the two preparations in any variable studied.
Authors' conclusions
there is no significant difference between Pancrease and Creon when compared on a capsule for capsule basis.